Hepamerz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

## Hepamerz (l-Ornithine l-Aspartate) ### Overview Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is used in the management of hyperammonemia associated with liver dysfunction. ### Primary Indications * Treatment of latent and manifest hepatic encephalopathy. ### Adult Dosing * **Hepatic Encephalopathy:** 3 g (one sachet) orally three times daily. The total daily dose should not exceed 9 g. In severe cases, intravenous administration may be considered, but specific dosing for IV use depends on local protocols. ### Pediatric Dosing * Pediatric dosing has not been definitively established. Use should be guided by the treating physician and may be based on extrapolated adult data or specific institutional guidelines. ### Dose Adjustments * No specific dose adjustments are typically recommended for renal or hepatic impairment, as the drug is metabolized and eliminated by the liver and kidneys. However, caution is advised in severe renal impairment. ### Contraindications * Severe renal insufficiency (creatinine > 3 mg/dL). * Hypersensitivity to l-ornithine, l-aspartate, or any component of the formulation. ### Adverse Effects * Gastrointestinal disturbances (nausea, vomiting, abdominal pain, diarrhea) are the most common side effects. * Rarely, rash, pruritus, or other hypersensitivity reactions may occur. ### Key Drug Interactions * No significant drug interactions are well-documented. ### Monitoring * Monitor for signs and symptoms of hepatic encephalopathy, including neurological status. * Assess for gastrointestinal side effects. * Monitor renal function, particularly in patients with pre-existing renal disease. ### Clinical Pearls * The efficacy of Hepamerz in improving cognitive function in hepatic encephalopathy is based on its proposed mechanism of reducing ammonia levels by stimulating urea synthesis (ornithine) and non-urea ammonia detoxification pathways (aspartate). * Oral administration should ideally be taken with meals to minimize gastrointestinal upset. **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify current prescribing information with the official product monograph or other reliable sources.